- Temperature Monitoring Devices
Maintaining proper temperatures for vaccine products is challenging, especially in places with extremely hot or cold climates, unreliable electricity, and weak transportation infrastructure. This three-part banner and these handouts display devices prequalified by the World Health Organization that assess vaccine handling quality, detect malfunctioning equipment, and prevent temperature fluctuations that can negatively impact vaccine potency and safety. These are part of the project Optimize traveling exhibit featuring immunization supply chain innovations being developed and tested around the world.
Publication date: August 2013
- Temperature Monitoring for Vaccine Quality
In collaboration with the Albanian Ministry of Health, project Optimize has installed a short message service–based system that monitors and logs temperature conditions in peripheral cold chain equipment. The team aims to assess the benefits of remote alarm systems over nonconnected temperature loggers.
Publication date: July 2012
- Temperature Recording System in National Vaccine Stores of Khartoum, Sudan, and Tehran, Iran
Both Iran and Sudan utilize an alarm-based temperature recording system to monitor the performance of their national immunization cold stores. To better the utility and application of such systems in other countries, this project Optimize report documents the benefits, challenges, and advantages of both Iran’s and Sudan’s systems.
Author: Haghgou, M
Publication date: May 2010
- A Test for Detection of HPV-16 E6
Demonstration of the use of a magnetic immunochromatographic strip (ICS) assay with a reader to detect recombinant HPV-16 E6. The magnetic ICS assay was able to detect as little as 2.6ng of protein. Presented at: 38th Annual Oak Ridge Conference, April 20, 2006; San Jose, CA.
Author: Peck R, Schweizer J, Weigl B, et al
Publication date: April 2006
- Three Water Filters Interchange the Rules: Working Together to Increase Access to Safe Water for Low-Income Families
PATH’s Safe Water Project is implementing innovative methods to enable commercial enterprises to produce, distribute, sell, and maintain effective household water treatment and safe storage (HWTS) products for low-income populations in multiple developing countries around the world. This poster summarizes PATH's product development process to design and commercialize an HWTS device that specifically meets the needs of low- and middle-income families. This poster was presented at the Water and Health: Where Science Meets Policy conference hosted by the University of North Carolina Water Institute in October 2011.
Author: Lennon P, Beddoe A, Zwisler G
Publication date: October 2011
- Training Health Workers in the Management of Sharps Waste
This training manual is available for downloading in four sectioons: first, the guide for facilitation; second, the guide for training injection providers; third, the guide for training waste handlers; and fourth, resources.
Author: Berman A; Nelson C
Publication date: 2005
- Training Manual: Training Providers on Packaging Nevirapine Oral Suspension Using the Nevirapine Infant-Dose Pouch
This manual assists programs in training staff for the introduction of the nevirapine infant-dose pouch into programs for the prevention of mother-to-child transmission of HIV (PMTCT). It is intended for adaptation based on individual program needs.
Author: Berman A; Brooke S
Publication date: 2006
- Training Vaccinators in a Time of Change
This article, from the October 2001 issue of Immunization Focus, describes one nongovernmental organization's experience of training with partners in countries. The article also includes examples of training initiatives developed by PATH's Children's Vaccine Program.
Publication date: 2001
- Translating Advocacy to Action at the Country Level
PATH is an innovator, researcher, implementation catalyst, and influential advocate on the global and country levels. This document highlights PATH's experience and expertise in translating data, knowledge, and messages to stimulate action by decision-makers in support of health innovations, policies, and sustainable resources.
Publication date: December 2012
- Treating Precancerous Cervical Lesions
Publication date: 2003
- Treatment Alternatives for Medical Waste Disposal
This document describes technology options for treating infectious medical waste, including incineration, chemical treatment, autoclaving, microwaving, and shredding/compacting. Performance issues, environmental impact, and perspectives from several developing countries are described.
Publication date: October 2005
- Treatment of Anemia With Iron-Fortified Rice in a School Lunch Program in Burundi
This poster describes the results of a study that evaluated the efficacy of using multiple-micronutrient fortified rice to improve the hemoglobin concentration and anemia prevalence of anemic schoolchildren in rural Burundi.
Author: Parker ME, Mosites E, Reider K, et al
Publication date: June 2014
- Tuberculosis: A Global Health Emergency (Outlook, vol. 17, no. 3)
Author: Nguyen T
Publication date: November 1999
Part of series: Outlook
- Ukraine Health Services Response to Pandemic Influenza: Provisional Guidelines for Ukraine's Health Services to Plan and Organize Measures to Combat Pandemic Influenza
This document provides the overall framework and specific operational procedures for Ukraine’s health sector response to an influenza pandemic. Its prime objectives are to reduce the health impact of a pandemic and minimize disruption to health and other essential services while maintaining business continuity and reducing the disruption to society.
Publication date: July 2009
- Ultra Rice Technology Research Summary Table
The Ultra Rice technology has been intensively studied to ensure it is efficacious, shelf stable, and acceptable to consumers. This table outlines the 30 studies conducted to date that form the growing evidence base for the Ultra Rice fortification technology.
Publication date: October 2013
- Ultra Rice® Technology
Part of the Technology Updates series, this fact sheet describes the Ultra Rice project at PATH.
Publication date: August 2013
Part of series: Technology Updates
- Ultra Rice® Technology: Acceptable Micronutrient Losses and Limited Microbial Growth Enable Shelf Life Extension
This poster provides an overview of a study to determine whether grains fortified with the Ultra Rice® technology were safe for consumption and effective after being stored for 24 months.
Author: Tripathi R, Parker ME, Chanin Z, et al
Publication date: June 2014
- UN Commission on Life-Saving Commodities Technical Reference Team Briefs
The UN Commission on Life-Saving Commodities for Women and Children (the Commission) was formed in 2012 by the UN Secretary-General as a part of the Every Woman Every Child movement. The Commission’s framework for action outlines a priority list of 13 commodities and 10 cross-cutting recommendations to rapidly increase access and use. To help carry forward the Commission’s recommendations at the global and national levels, Global Technical Reference Teams (TRT) were established. One group was formed for each of the 13 commodities and 10 recommendations, and an advocacy working group is dedicated to advancing their cross-cutting goals. The advocacy working group, convened by PATH, developed a series of briefs highlighting the major goals, challenges, and activities of each TRT.
Publication date: July 2013
- Understanding Vaccines
This fact sheet on understanding vaccines describes how vaccines work and lists the different types of vaccines.
Publication date: May 2013
- The Uniject Injection System: Multi-country Experience and Evidence
This brief summarizes key findings from a literature review conducted by PATH to identify published and gray literature reporting international experiences with the Uniject™ injection system. The findings shed light on user acceptability and highlight potential cost savings in terms of training time, waste management, and reduction in drug wastage when Uniject is used instead of a standard autodisable syringe. This document synthesizes the experience and evidence on the use of Uniject worldwide with medicines such as the injectable contraceptive Cyclofem®, hepatitis B and tetanus toxoid vaccines, as well as the drug oxytocin, which is used to prevent postpartum hemorrhage.
Publication date: February 2011